The Regulatory Effects of Pea Protein Hydrolysate on Lipid Metabolism in Gestational Diabetic Mice
Molecular Nutrition & Food Research · 2025
DOI: 10.1002/mnfr.70178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Tingqing Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Nutrition and Food Hygiene, School of Public Health,…. Hauptthemen laut MEDLINE: Diabetes, Gestational, Lipid Metabolism, Protein Hydrolysates, Pea Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Gestational diabetes mellitus (GDM) poses significant risks to maternal health and adverse metabolic outcomes in offspring. Pea protein hydrolysate (PPH), a kind of bioactive peptide with anti‐diabetic properties, was evaluated for its therapeutic potential in the GDM mouse model. While PPH exhibited mild glucose‐lowering effects, high‐dose PPH (1000 mg/kg/day) significantly ameliorated insulin resistance and systemic dyslipidemia, including reductions in serum triglycerides, total cholesterol, low‐density lipoprotein cholesterol, and hepatic lipid accumulation. In addition, the PPH treatment could significantly modulate the placental pathology. Thus, a mechanistic study was conducted from the view of placental lipid metabolism. It was found that the inhibition of the PI3K/AKT/mTOR/PPARγ signaling pathway was involved in the mechanisms of action of PPH, which successfully prevented excessive placental lipid accumulation and ensured that the key structures of the placenta remained in the original state. Furthermore, PPH alleviated the GDM‐induced reduction in placental phosphatidylcholine (PC) and phosphatidylethanolamine (PE) levels, restoring two functionally critical lipid species: PC (16:0/20:4) and FAHFA (26:1/22:3). Collectively, PPH showed the potential to mitigate GDM‐associated metabolic disturbances and placental dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing, Jiangsu, 210009, China.
- College of Engineering, China Agricultural University, Beijing, China.
- Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China.
- Public Service Platform of South China Sea for R&D Marine Biomedicine Resources, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, Guangdong, China.
ORCID-Profile: Tingqing Yu, Guiju Sun
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yu, T., Shang, N., Chen, L., Lu, K., Xia, H., Yang, L., Wang, S., Sun, G., & Liao, W. (2025). The Regulatory Effects of Pea Protein Hydrolysate on Lipid Metabolism in Gestational Diabetic Mice. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70178
Vancouver
Yu T, Shang N, Chen L, Lu K, Xia H, Yang L, et al. The Regulatory Effects of Pea Protein Hydrolysate on Lipid Metabolism in Gestational Diabetic Mice. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70178
BibTeX
@article{Yu2025,
author = {Yu, Tingqing and Shang, Nan and Chen, Liang and Lu, Kun and Xia, Hui and Yang, Ligang and Wang, Shaokang and Sun, Guiju and Liao, Wang},
title = {The Regulatory Effects of Pea Protein Hydrolysate on Lipid Metabolism in Gestational Diabetic Mice},
journal = {Molecular Nutrition & Food Research},
year = {2025},
doi = {10.1002/mnfr.70178}
}
EUVIMED